Hls Therapeutics, Inc. · TSX:HLS
Hls Therapeutics — Shareholder Meeting (June 2022)
10 slides from Hls Therapeutics's shareholder meeting presentation, Jun 17, 2022
Slide 1: Annual Meeting
Annual Meeting June 17, 2022 TSX - HLS
Slide 2: Forward-looking statements
Forward-looking statements Certain statements in this presentation are “forward-looking statements”. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not alwa
Slide 3: Formal Business
Formal Business 1. Presentation of financial statements 2. Election of directors 3. Re-appointment of auditors TSX - HLS HLS THERAPEUTICS INC. 3
Slide 4: Election of Directors
Election of Directors Greg Gubitz, Chair Don DeGolyer Gilbert Godin, CEO Rodney Hill Yvon Bastien J. Spencer Lanthier Norma Beauchamp John Welborn Laura Brege TSX - HLS HLS THERAPEUTICS INC. 4
Slide 5: Re-Appointment of Auditors
Re-Appointment of Auditors Ernst & Young LLP TSX - HLS HLS THERAPEUTICS INC. 5
Slide 6: Annual Meeting
Annual Meeting June 17, 2022 TSX - HLS
Slide 7: 2021 & YTD 2022: Foundation for Growth
2021 & YTD 2022: Foundation for Growth Highlights Vascepa Highlights Private payer coverage: 2021 Revenue: $60MM, up 7% >90% privately covered lives eligible for Vascepa reimbursement 2021 Adjusted EBITDA: $26.3MM, up 9% Public payer coverage: agreed to terms with the pCPA for public reimbursement o
Slide 8: Vascepa: Prescription Momentum Growing
Vascepa: Prescription Momentum Growing 900 Weekly script data since launch 800 700 600 111% Year-over-year in Rx increase Prescriptions 500 Year-over-year increase 400 177% in prescribing doctors to 2,025 300 Year-over-year increase 139% in patients to 6,945 200 100 0 *year-over-year increase as at
Slide 9: HLS Virtual Non-Deal Roadshow
HLS Virtual Non-Deal Roadshow Investor presentation followed by Q&A Date: June 22, 2022 Time: 12:00pm ET Access: link available in the Event section of the HLS website Source: Weekly Rx, 2020 - 2022, IQVIA 9 Provided as part of an oral presentation and qualified by such, contains forward-looking sta
Slide 10: Annual Meeting
Annual Meeting June 17, 2022 TSX - HLS